Literature DB >> 8882634

Stimulation by the nucleotides, ATP and UTP of mitogen-activated protein kinase in EAhy 926 endothelial cells.

A Graham1, A McLees, C Kennedy, G W Gould, R Plevin.   

Abstract

1. We have investigated the characteristics of activation of the 42kDa isoform of mitogen-activated protein (MAP) kinase in response to various nucleotides in the endothelial cell line EAhy 926. 2. Adenosine 5'-triphosphate (ATP) in the concentration range 0.1-100 microM stimulated the rapid and transient tyrosine phosphorylation and activation of the 42 kDa isoform of MAP kinase in EAhy 926 endothelial cells which peaked at 2 min and returned to basal values by 60 min. ATP also stimulated a similar response in primary cultured bovine aortic endothelial cells. 3. Uridine 5' triphosphate (UTP) also stimulated the 42 kDa isoform of MAP kinase with similar potency to ATP (EC50 values 5.1 +/- 0.2 microM for UTP; 2.9 +/- 0.8 microM for ATP), whilst the selective P2Y-purinoceptor agonist, 2-methylthioATP (2-meSATP) was without effect up to concentrations of 100 microM. In bovine aortic endothelial cells however, UTP and 2-meSATP both stimulated MAP kinase. 4. Pretreatment of cells for 24 h with 12-O tetradecanoyl phorbol 13-acetate resulted in the loss of the alpha and epsilon isoforms of protein kinase C (PKC) and virtual abolition of nucleotide-stimulated MAP kinase activity (> 90% inhibition). 5. Preincubation for 30 min with the PKC inhibitor, Ro-31 8220 (10 microM) reduced MAP-kinase activation at 2 min but potentiated the response at 60 min. 6. Removal of extracellular calcium in the presence of EGTA reduced the MAP kinase activation in response to UTP by approximately 30-50%. 7. Pretreatment with pertussis toxin (18 h, 50 ng ml-1) did not significantly affect the UTP-mediated activation of pp42 MAP kinase. 8. These results show that in the EAhy 926 endothelial cell line, nucleotides stimulate activation of MAP kinase in a protein kinase C-dependent manner through interaction with a P2U-purinoceptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882634      PMCID: PMC1909785          DOI: 10.1111/j.1476-5381.1996.tb16734.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

Review 1.  P1- and P2-purinoceptor subtypes--an update.

Authors:  C Kennedy
Journal:  Arch Int Pharmacodyn Ther       Date:  1990 Jan-Feb

2.  Pattern of protein phosphorylation in aortic endothelial cells. Modulation by adenine nucleotides and bradykinin.

Authors:  D Demolle; M Lecomte; J M Boeynaems
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

Review 3.  P2 purinoceptors on vascular endothelial cells: physiological significance and transduction mechanisms.

Authors:  J M Boeynaems; J D Pearson
Journal:  Trends Pharmacol Sci       Date:  1990-01       Impact factor: 14.819

4.  Permanent cell line expressing human factor VIII-related antigen established by hybridization.

Authors:  C J Edgell; C C McDonald; J B Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  Stimulation of prostaglandin production through purinoceptors on cultured porcine endothelial cells.

Authors:  J D Pearson; L L Slakey; J L Gordon
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

6.  Potent selective inhibitors of protein kinase C.

Authors:  P D Davis; C H Hill; E Keech; G Lawton; J S Nixon; A D Sedgwick; J Wadsworth; D Westmacott; S E Wilkinson
Journal:  FEBS Lett       Date:  1989-12-18       Impact factor: 4.124

7.  Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase.

Authors:  N G Anderson; J L Maller; N K Tonks; T W Sturgill
Journal:  Nature       Date:  1990-02-15       Impact factor: 49.962

8.  Comparison of P2 purinergic receptors of aortic endothelial cells with those of adrenal medulla: evidence for heterogeneity of receptor subtype and of inositol phosphate response.

Authors:  D J Allsup; M R Boarder
Journal:  Mol Pharmacol       Date:  1990-07       Impact factor: 4.436

9.  Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells.

Authors:  M Kelm; M Feelisch; R Spahr; H M Piper; E Noack; J Schrader
Journal:  Biochem Biophys Res Commun       Date:  1988-07-15       Impact factor: 3.575

10.  Intracellular pH changes of cultured bovine aortic endothelial cells in response to ATP addition.

Authors:  T Kitazono; K Takeshige; E J Cragoe; S Minakami
Journal:  Biochem Biophys Res Commun       Date:  1988-05-16       Impact factor: 3.575

View more
  4 in total

1.  Characterisation of P2Y2 receptors in human vascular endothelial cells using AR-C118925XX, a competitive and selective P2Y2 antagonist.

Authors:  Markie O Muoboghare; Robert M Drummond; Charles Kennedy
Journal:  Br J Pharmacol       Date:  2019-07-06       Impact factor: 8.739

2.  P(2Y) purinoceptor subtypes recruit different mek activators in astrocytes.

Authors:  G Lenz; C Gottfried; Z Luo; J Avruch; R Rodnight; W J Nie; Y Kang; J T Neary
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

3.  Phosphorylation and activation of p42 and p44 mitogen-activated protein kinase are required for the P2 purinoceptor stimulation of endothelial prostacyclin production.

Authors:  V Patel; C Brown; A Goodwin; N Wilkie; M R Boarder
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

4.  Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks.

Authors:  Kristof Van Kolen; Herman Slegers
Journal:  Purinergic Signal       Date:  2006-06-07       Impact factor: 3.765

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.